EPO and retinoblastoma: In this study, we aimed to genetically modify MSCs to produce and secrete human EPO protein and to demonstrate the high potential of dual combination of EPO delivered by MSCs to protect retinal neurons from apoptosis in a glutamate-induced human retinoblastoma (Y79) in vitro model.